Advertisements



Gemphire Therapeutics announces termination of Phase 2a trial of gemcabene

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow.....»»

Category: topSource: seekingalphaJun 29th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Menlo Therapeutics announces publication of Phase 2 serlopitant trial data

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall19 hr. 23 min. ago

TG Therapeutics announces initiation of Phase I TG-1801 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 26th, 2019

Miragen Therapeutics announces data from Phase 1 cobomarsen trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 10th, 2019

G1 Therapeutics announces data from Phase 2 trial evaluating trilaciclib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 4th, 2018

Miragen Therapeutics announces data from Phase 1 Cobomarsen trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 2nd, 2018

G1 Therapeutics announces data from phase 2 trilaciclib trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 26th, 2018

G1 Therapeutics announces new data from Phase 2 trilaciclib trial at ESMO

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 9th, 2018

Galectin Therapeutics announces preliminary data from Phase 1b trial of GR-MD-02

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 20th, 2018

Cara Therapeutics announces dosing of patients in Phase 2 trial of Oral Korsuva

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 11th, 2018

Aclaris Therapeutics announces data for ATI-502 Phase 2 trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 28th, 2018

Sage Therapeutics announces pivotal Phase 3 trial for SAGE-217

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Tenax Therapeutics announces study design for Phase 2 Trial of levosimendan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2018

Menlo Therapeutics announces results from Phase 2 trial of Serlopitant

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 8th, 2018

aTyr Pharma Announces Fourth Quarter and Full Year 2018 Results and Provides Corporate Update

Phase 1b/2a proof-of-concept clinical trial of ATYR1923 in pulmonary sarcoidosis patients initiated in December 2018 First tRNA synthetase partnership announced in March 2019 SAN DIEGO, March .....»»

Category: earningsSource: benzinga11 hr. 23 min. ago

Ascendis Pharma announces top-line results from Phase 3 heiGHt trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 24th, 2019

Conatus announces Phase 2b ENCORE-NF trial results

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 21st, 2019

Inovio Pharmaceuticals stock up 9% after company announces positive data from Phase 1 trial of Ebola vaccine

Shares of Inovio Pharmaceuticals Inc. rose 9% in premarket trade Thursday after the company announced that its investigational Ebola vaccine .....»»

Category: topSource: marketwatchMar 21st, 2019

Opko Health announces results from Phase 2 trial of OPK88003

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 21st, 2019